Original
Tocilizumab en pacientes con artritis reumatoide activa y respuesta inadecuada a fármacos antirreumáticos modificadores de la enfermedad o antagonistas del factor de necrosis tumoral: subanálisis de los datos españoles de un estudio abierto cercano a la práctica clínica habitual
Tocilizumab in patients with active rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs or tumor necrosis factor inhibitors: Subanalysis of Spanish results of an open-label study close to clinical practice
José M. Álvaro-Graciaa,
, Antonio Fernández-Nebrob, Alicia García-Lópezc, Manuel Guzmánd, Francisco J. Blancoe, Francisco J. Navarrof, Sagrario Bustabadg, Yolanda Armendárizh, José A. Román-Ivorrai, ACT SURE ◊
Autor para correspondencia
a Servicio de Reumatología, Unidad de Terapias Biológicas, Hospital Universitario de La Princesa, Madrid, España
b Servicio de Reumatología, Hospital Regional Universitario Carlos Haya, Universidad de Málaga, Málaga, España
c Servicio de Reumatología, Hospital Universitario Virgen del Rocío, Sevilla, España
d Servicio de Reumatología, Hospital Universitario Virgen de las Nieves, Granada, España
e Servicio de Reumatología, Complejo Universitario Hospitalario de A Coruña, A Coruña, España
f Servicio de Reumatología, Hospital Universitario de Elche, Elche, Alicante, España
g Servicio de Reumatología, Hospital Universitario de Canarias, La Laguna, Tenerife, España
h Departamento Médico, Roche, Madrid, España
i Servicio de Reumatología, Hospital Universitario La Fe, Valencia, España
Ver másLeído
18457
Vecesse ha leído el artículo
4211
Total PDF
14246
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 2 | 37 | 39 |
| 2025 5 | 236 | 59 | 295 |
| 2025 4 | 164 | 28 | 192 |
| 2025 3 | 211 | 39 | 250 |
| 2025 2 | 214 | 37 | 251 |
| 2025 1 | 199 | 62 | 261 |
| 2024 12 | 156 | 30 | 186 |
| 2024 11 | 183 | 79 | 262 |
| 2024 10 | 136 | 38 | 174 |
| 2024 9 | 141 | 12 | 153 |
| 2024 8 | 143 | 30 | 173 |
| 2024 7 | 154 | 30 | 184 |
| 2024 6 | 160 | 51 | 211 |
| 2024 5 | 148 | 39 | 187 |
| 2024 4 | 132 | 31 | 163 |
| 2024 3 | 134 | 39 | 173 |
| 2024 2 | 110 | 23 | 133 |
| 2024 1 | 157 | 28 | 185 |
| 2023 12 | 119 | 30 | 149 |
| 2023 11 | 103 | 31 | 134 |
| 2023 10 | 194 | 33 | 227 |
| 2023 9 | 231 | 50 | 281 |
| 2023 8 | 134 | 20 | 154 |
| 2023 7 | 155 | 31 | 186 |
| 2023 6 | 151 | 39 | 190 |
| 2023 5 | 124 | 27 | 151 |
| 2023 4 | 155 | 19 | 174 |
| 2023 3 | 204 | 33 | 237 |
| 2023 2 | 151 | 36 | 187 |
| 2022 1 | 139 | 16 | 155 |
| 2022 12 | 140 | 39 | 179 |
| 2022 11 | 159 | 43 | 202 |
| 2022 10 | 165 | 40 | 205 |
| 2022 9 | 169 | 28 | 197 |
| 2022 8 | 159 | 62 | 221 |
| 2022 7 | 122 | 49 | 171 |
| 2022 6 | 160 | 57 | 217 |
| 2022 5 | 156 | 56 | 212 |
| 2022 4 | 150 | 58 | 208 |
| 2022 3 | 145 | 64 | 209 |
| 2022 2 | 148 | 35 | 183 |
| 2021 1 | 206 | 55 | 261 |
| 2021 12 | 140 | 56 | 196 |
| 2021 11 | 156 | 52 | 208 |
| 2021 10 | 151 | 54 | 205 |
| 2021 9 | 141 | 65 | 206 |
| 2021 8 | 96 | 57 | 153 |
| 2021 7 | 95 | 46 | 141 |
| 2021 6 | 188 | 45 | 233 |
| 2021 5 | 144 | 49 | 193 |
| 2021 4 | 210 | 79 | 289 |
| 2021 3 | 156 | 50 | 206 |
| 2021 2 | 131 | 39 | 170 |
| 2020 1 | 82 | 35 | 117 |
| 2020 12 | 69 | 22 | 91 |
| 2020 11 | 58 | 24 | 82 |
| 2020 10 | 59 | 18 | 77 |
| 2020 9 | 86 | 41 | 127 |
| 2020 8 | 111 | 56 | 167 |
| 2020 7 | 92 | 39 | 131 |
| 2020 6 | 129 | 40 | 169 |
| 2020 5 | 148 | 31 | 179 |
| 2020 4 | 193 | 51 | 244 |
| 2020 3 | 271 | 27 | 298 |
| 2020 2 | 46 | 46 | 92 |
| 2020 1 | 53 | 21 | 74 |
| 2019 12 | 82 | 37 | 119 |
| 2019 11 | 51 | 17 | 68 |
| 2019 10 | 49 | 23 | 72 |
| 2019 9 | 57 | 16 | 73 |
| 2019 8 | 64 | 25 | 89 |
| 2019 7 | 88 | 34 | 122 |
| 2019 6 | 124 | 38 | 162 |
| 2019 5 | 130 | 108 | 238 |
| 2019 4 | 100 | 43 | 143 |
| 2019 3 | 79 | 40 | 119 |
| 2019 2 | 80 | 30 | 110 |
| 2019 1 | 79 | 37 | 116 |
| 2018 12 | 104 | 72 | 176 |
| 2018 11 | 90 | 23 | 113 |
| 2018 10 | 57 | 13 | 70 |
| 2018 9 | 73 | 8 | 81 |
| 2018 8 | 59 | 13 | 72 |
| 2018 7 | 20 | 6 | 26 |
| 2018 5 | 6 | 2 | 8 |
| 2018 4 | 81 | 16 | 97 |
| 2018 3 | 74 | 8 | 82 |
| 2018 2 | 57 | 6 | 63 |
| 2018 1 | 46 | 8 | 54 |
| 2017 12 | 44 | 9 | 53 |
| 2017 11 | 58 | 10 | 68 |
| 2017 10 | 55 | 16 | 71 |
| 2017 9 | 58 | 10 | 68 |
| 2017 8 | 105 | 33 | 138 |
| 2017 7 | 58 | 22 | 80 |
| 2017 6 | 90 | 43 | 133 |
| 2017 5 | 101 | 21 | 122 |
| 2017 4 | 91 | 14 | 105 |
| 2017 3 | 101 | 28 | 129 |
| 2017 2 | 53 | 22 | 75 |
| 2016 1 | 51 | 10 | 61 |
| 2016 12 | 95 | 23 | 118 |
| 2016 11 | 100 | 18 | 118 |
| 2016 10 | 143 | 29 | 172 |
| 2016 9 | 192 | 11 | 203 |
| 2016 8 | 94 | 9 | 103 |
| 2016 7 | 61 | 10 | 71 |
| 2016 6 | 1 | 0 | 1 |
| 2016 5 | 1 | 0 | 1 |
| 2016 2 | 1 | 0 | 1 |
| 2015 12 | 2 | 0 | 2 |
| 2015 9 | 1 | 0 | 1 |
| 2015 8 | 3 | 0 | 3 |
| 2015 7 | 52 | 10 | 62 |
| 2015 6 | 77 | 25 | 102 |
| 2015 5 | 70 | 26 | 96 |
| 2015 4 | 78 | 33 | 111 |
| 2015 3 | 81 | 30 | 111 |
| 2015 2 | 59 | 18 | 77 |
| 2015 1 | 90 | 25 | 115 |
| 2014 12 | 64 | 18 | 82 |
| 2014 11 | 58 | 39 | 97 |
| 2014 10 | 74 | 29 | 103 |
| 2014 9 | 50 | 33 | 83 |
| 2014 8 | 77 | 23 | 100 |
| 2014 7 | 99 | 31 | 130 |
| 2014 6 | 119 | 34 | 153 |
| 2014 5 | 108 | 47 | 155 |
| 2014 4 | 201 | 75 | 276 |
| 2014 3 | 156 | 68 | 224 |
Mostrar todo
